Lung Cancer pp 35-56 | Cite as

Thoracic Imaging Techniques for Non-Small Cell and Small Cell Lung Cancer

  • Reginald F. Munden
  • Jeremy J. Erasmus
Part of the M.D. Anderson Cancer Care Series book series (MDCCS)


Lung Cancer Small Cell Lung Cancer Adrenal Mass Malignant Pleural Effusion Bronchogenic Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Readings

  1. Abrams J, Doyle LA, Aisner J. Staging, prognostic factors, and special considerations in small cell lung cancer. Semin Oncol 1988;15:261–277.PubMedGoogle Scholar
  2. Ahuja V, Coleman RE, Herndon J, et al. The prognostic significance of fluorodeoxyglucose positron emission tomography imaging for patients with non-small cell lung carcinoma. Cancer 1998;83:918–924.CrossRefPubMedGoogle Scholar
  3. American Thoracic Society and European Respiratory Society. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med 1997; 156:320–332.Google Scholar
  4. Boland GW, Lee MJ. Magnetic resonance imaging of the adrenal gland. Crit Rev Diagn Imaging 1995;36:115–174.PubMedGoogle Scholar
  5. Boland GW, Lee MJ, Gazelle GS, et al. Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 1998;171:201–204.PubMedGoogle Scholar
  6. Bury T, Corhay JL, Duysinx B, et al. Value of FDG-PET in detecting residual or recurrent nonsmall cell lung cancer. Eur Respir J 1999;14:1376–1380.CrossRefPubMedGoogle Scholar
  7. Colice GL, Birkmeyer JD, Black WC, et al. Cost-effectiveness of head CT in patients with lung cancer without clinical evidence of metastases. Chest 1995;108:1264–1271.PubMedGoogle Scholar
  8. Darling GE. Staging of the patient with small cell lung cancer. Chest Surg Clin N Am 1997;7:81–94.PubMedGoogle Scholar
  9. Dewan NA, Gupta NC, Redepenning LS, et al. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management. Chest 1993;104:997–1002.PubMedGoogle Scholar
  10. Dhital K, Saunders CA, Seed PT, et al. [(18)F]Fluorodeoxyglucose positron emission tomography and its prognostic value in lung cancer. Eur J Cardiothorac Surg 2000;18:425–428.CrossRefPubMedGoogle Scholar
  11. Dietlein M, Weber K, Gandjour A, et al. Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results. Eur J Nucl Med 2000;27:1598–1609.CrossRefPubMedGoogle Scholar
  12. Dwamena BA, Sonnad SS, Angobaldo JO, et al. Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT. Radiology 1999;213:530–536.PubMedGoogle Scholar
  13. Ginsberg MS, Griff SK, Go BD, et al. Pulmonary nodules resected at video-assisted thoracoscopic surgery: etiology in 426 patients. Radiology 1999;213:277–282.PubMedGoogle Scholar
  14. Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:936–937.CrossRefGoogle Scholar
  15. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 1992;184:441–444.PubMedGoogle Scholar
  16. Henschke CI, McCauley DI, Yankelevitz DF, et al. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet 1999;354:99–105.CrossRefPubMedGoogle Scholar
  17. Hooper RG, Tenholder MF, Underwood GH, et al. Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma. Chest 1984;85:774–776.PubMedGoogle Scholar
  18. Kalff V, Hicks RJ, MacManus M, et al. Clinical impact of (18)F fluorodeoxyglucose positron emission tomography in patients with non-small-cell lung cancer: a prospective study. J Clin Oncol 2001;19:111–118.PubMedGoogle Scholar
  19. Kaneko N, Eguchi K, Ohmatsu H, et al. Peripheral lung cancer: screening and detection with low-dose spiral CT vs. radiography. Radiology 1996;201:798–802.PubMedGoogle Scholar
  20. Klein JS, Salomon G, Stewart EA. Transthoracic needle biopsy with a coaxially placed 20-gauge automated cutting needle: results in 122 patients. Radiology 1996;198:715–720.PubMedGoogle Scholar
  21. Klein JS, Webb WR. The radiologic staging of lung cancer. J Thorac Imaging 1991;7:29–47.PubMedGoogle Scholar
  22. Klein JS, Zarka MA. Transthoracic needle biopsy: an overview. J Thorac Imaging 1997;12:232–249.PubMedCrossRefGoogle Scholar
  23. Knight SB, Delbeke D, Stewart JR, et al. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest 1996;109:982–988.PubMedGoogle Scholar
  24. Kubik A, Parkin DM, Khlat M, et al. Lack of benefit from semi-annual screening of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 1990;45:26–33.PubMedGoogle Scholar
  25. Li H, Boiselle PM, Shepard JO, et al. Diagnostic accuracy and safety of CT-guided percutaneous needle aspiration biopsy of the lung: comparison of small and large pulmonary nodules. AJR Am J Roentgenol 1996;167:105–109.PubMedGoogle Scholar
  26. Mahoney MC, Shipley RT, Corcoran HL, et al. CT demonstration of calcification in carcinoma of the lung. AJR Am J Roentgenol 1990;154:255–258.PubMedGoogle Scholar
  27. Martini N, Heelan R, Westcott J, et al. Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma. J Thorac Cardiovasc Surg 1985;90:639–648.PubMedGoogle Scholar
  28. McLoud TC, Bourgouin PM, Greenberg RW, et al. Bronchogenic carcinoma: analysis of staging in the mediastinum with CT by correlative lymph node mapping and sampling. Radiology 1992;182:319–323.PubMedGoogle Scholar
  29. Mintz BJ, Tuhrim S, Alexander S, et al. Intracranial metastases in the initial staging of bronchogenic carcinoma. Chest 1984;86:850–853.PubMedGoogle Scholar
  30. Moore EH. Needle-aspiration lung biopsy: a comprehensive approach to complication reduction. J Thorac Imaging 1997;12:259–271.PubMedGoogle Scholar
  31. Mori K, Tominaga K, Hirose T, et al. Utility of low-dose helical CT as a second step after plain chest radiography for mass screening for lung cancer. J Thorac Imaging 1997;12:173–180.PubMedGoogle Scholar
  32. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710–1717.PubMedGoogle Scholar
  33. Munden RF, Pugatch RD, Liptay MJ, et al. Small pulmonary lesions detected at CT: clinical importance. Radiology 1997;202:105–110.PubMedGoogle Scholar
  34. Musset D, Grenier P, Carette MF, et al. Primary lung cancer staging: prospective comparative study of MR imaging with CT. Radiology 1986;160:607–611.PubMedGoogle Scholar
  35. Patz EF Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487–490.PubMedGoogle Scholar
  36. Protopapas Z, Westcott JL. Transthoracic hilar and mediastinal biopsy. J Thorac Imaging 1997;12:250–258.PubMedGoogle Scholar
  37. Quint LE, Francis IR, Wahl RL, et al. Preoperative staging of non-small-cell carcinoma of the lung: imaging methods. AJR Am J Roentgenol 1995;164:1349–1359.PubMedGoogle Scholar
  38. Richert-Boe K, Humphrey LL. Screening for cancers of the lung and colon. Arch Intern Med 1992;152:2398–2404.CrossRefPubMedGoogle Scholar
  39. Seemann MD, Staebler A, Beinert T, et al. Usefulness of morphological characteristics for the differentiation of benign from malignant solitary pulmonary lesions using HRCT. Eur Radiol 1999;9:409–417.CrossRefPubMedGoogle Scholar
  40. Strauss GM. Measuring effectiveness of lung cancer screening: from consensus to controversy and back. Chest 1997;112:216S–228S.PubMedGoogle Scholar
  41. Swensen SJ, Harms GF, Morin RL, et al. CT evaluation of solitary pulmonary nodules: value of 185-H reference phantom. AJR Am J Roentgenol 1991;156:925–929.PubMedGoogle Scholar
  42. Swensen SJ, Viggiano RW, Midthun DE, et al. Lung nodule enhancement at CT: multicenter study. Radiology 2000;214:73–80.PubMedGoogle Scholar
  43. Valk PE, Pounds TR, Hopkins DM, et al. Staging non-small cell lung cancer by whole-body positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573–1581.CrossRefPubMedGoogle Scholar
  44. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in staging non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705–713.PubMedGoogle Scholar
  45. Weder W, Schmid RA, Bruchhaus H, et al. Detection of extrathoracic metastases by positron emission tomography in lung cancer. Ann Thorac Surg 1998;66:886–892.CrossRefPubMedGoogle Scholar
  46. Westcott JL, Rao N, Colley DP. Transthoracic needle biopsy of small pulmonary nodules. Radiology 1997;202:97–103.PubMedGoogle Scholar
  47. Yankelevitz DF, Gupta R, Zhao B, et al. Small pulmonary nodules: evaluation with repeat CT—preliminary experience. Radiology 1999;212:561–566.PubMedGoogle Scholar
  48. Yankelevitz DF, Henschke CI. Does 2-year stability imply that pulmonary nodules are benign? AJR Am J Roentgenol 1997;168:325–328.PubMedGoogle Scholar
  49. Yankelevitz DF, Reeves AP, Kostis WJ, et al. Determination of malignancy in small pulmonary nodules based on volumetrically determined growth rates. Radiology 2000;209(suppl): 375.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 2003

Authors and Affiliations

  • Reginald F. Munden
  • Jeremy J. Erasmus

There are no affiliations available

Personalised recommendations